Jeffrey Farrow Net Worth & Insider Trades

Jeffrey Farrow - Chief Financial Officer, Global Blood Therapeutics, Inc

As of October 6, 2022

What is Jeffrey Farrow's Net Worth?

The current estimated net worth of Global Blood Therapeutics, Inc's Chief Financial Officer, Jeffrey Farrow, is estimated to be about $5.38M . Jeffrey Farrow owns about 3,086 units of Global Blood Therapeutics, Inc common stock. In the last 5 years at Global Blood Therapeutics, Inc, Jeffrey Farrow has sold an estimated value of $6.69M worth.

What is Jeffrey Farrow's Past Insider Trading?

Jeffrey Farrow's largest sale order was 33,326 units , worth over $2.27M on September 6, 2022. In total, Jeffrey Farrow has made about 28 transactions over 5 years of their time at Global Blood Therapeutics, Inc. Jeffrey Farrow usually trades in August, with the busiest year in 2022 and 2018.

Jeffrey Farrow

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Jeffrey Farrow's Salary in 2020?

As Chief Financial Officer of Global Blood Therapeutics, Inc, Jeffrey Farrow has a total base salary of $457,813 . Jeffrey Farrow received compensation valued at about $5,985,078 in 2020 after becoming Chief Financial Officer. The vast majority of their compensation came in the form of stock awards of $3,708,261 , option awards of $1,582,504 , other earnings, plans or compensations of $231,500 , and other compensation of $5,000 .

What is Jeffrey Farrow's' Mailing Address?

  • Mailing address is Two Corporate Drive South San Francisco CA 94080 CA

Global Blood Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Ted Love, M.D. 2020 $661,250 - $11,778,840 $4,693,666 $467,000 $5,000 $17,605,756
Ted Love, M.D. 2019 $596,876 - $4,359,600 $4,595,717 $540,000 $5,000 $10,097,193
Ted Love, M.D. 2018 $568,750 - $4,648,800 $4,623,690 $414,000 $5,000 $10,260,240
David Johnson 2020 $463,750 - $4,037,361 $1,582,504 $234,000 $5,000 $6,322,615
David Johnson 2019 $453,125 - $1,211,000 $1,267,784 $250,000 $5,000 $3,186,909
David Johnson 2018 $355,000 $75,000 $1,897,750 $1,898,534 $169,000 $5,000 $4,394,284
Jeffrey Farrow 2020 $457,813 - $3,708,261 $1,582,504 $231,500 $5,000 $5,985,078
Jeffrey Farrow 2019 $440,625 - $1,211,000 $1,267,784 $244,000 $5,000 $3,168,409
Jeffrey Farrow 2018 $425,938 - $1,370,800 $1,326,469 $201,000 $5,000 $3,329,207
Jung Choi 2020 $433,125 - $3,708,261 $1,582,504 $219,000 $5,000 $5,947,890
Jung Choi 2019 $416,875 - $1,211,000 $1,267,784 $231,000 $5,000 $3,131,659
Jung Choi 2018 $392,063 - $1,370,800 $1,326,469 $185,000 $5,000 $3,279,332
Tricia Suvari 2020 $422,499 - $3,708,261 $1,582,504 $214,000 $5,000 $5,932,264
Tricia Suvari 2019 $403,125 - $1,211,000 $1,267,784 $223,000 $5,000 $3,109,909
Tricia Suvari 2018 $386,875 - $1,549,600 $1,515,964 $183,000 $5,000 $3,640,439
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1629137/000119312521136815/d97499ddef14a.htm

What are Global Blood Therapeutics, Inc's Past Insider Trades?

Global Blood Therapeutics, Inc's most recent insider trade came on September 6, 2022 by Jeffrey Farrow who sold 33,326 units worth $2.27M . In the last 7 years, insiders at Global Blood Therapeutics, Inc have sold an estimated value of $167.81M and bought an estimated value of $17.45M worth of shares. Insider trading is most common in June, with the busiest year in 2022. The most active traders at the company are Jung Choi, See Remarks,  Ted Love, President and CEO,  and Borga Tricia Suvari, Chief Legal Officer .

Global Blood Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1